PMS-PRUCALOPRIDE DIN 02499940
Status: Cancelled Pre Market
Holder: PHARMASCIENCE INC
Molecule: PRUCALOPRIDE (PRUCALOPRIDE SUCCINATE)
Health Canada record
| Active ingredient(s) | PRUCALOPRIDE (PRUCALOPRIDE SUCCINATE) 1 MG |
|---|---|
| Dosage form | Tablet |
| Route | Oral |
| Schedule | PRESCRIPTION |
| Class | Human |
| ATC | A06AX05 PRUCALOPRIDE |
| Original market date | |
| Current status date | 31-Jul-2026 |
| Source | Health Canada DPD |
Establishment licence of the holder
Pharmascience Inc. — licence 100241, currently licensed, last inspection rating C (2025-03-20).
No Canadian shortage report is currently matched to this DIN.
Other Canadian products containing PRUCALOPRIDE (PRUCALOPRIDE SUCCINATE)
| DIN | Product | Company | Form | Strength | Status |
|---|---|---|---|---|---|
| 02491591 | APO-PRUCALOPRIDE | APOTEX INC | Tablet | PRUCALOPRIDE (PRUCALOPRIDE SUCCINATE) 1 MG | Marketed |
| 02491605 | APO-PRUCALOPRIDE | APOTEX INC | Tablet | PRUCALOPRIDE (PRUCALOPRIDE SUCCINATE) 2 MG | Marketed |
| 02493489 | JAMP PRUCALOPRIDE | JAMP PHARMA CORPORATION | Tablet | PRUCALOPRIDE (PRUCALOPRIDE SUCCINATE) 1 MG | Marketed |
| 02493497 | JAMP PRUCALOPRIDE | JAMP PHARMA CORPORATION | Tablet | PRUCALOPRIDE (PRUCALOPRIDE SUCCINATE) 2 MG | Marketed |
| 02550377 | NRA-PRUCALOPRIDE | NORA PHARMA INC | Tablet | PRUCALOPRIDE (PRUCALOPRIDE SUCCINATE) 1 MG | Marketed |
| 02550385 | NRA-PRUCALOPRIDE | NORA PHARMA INC | Tablet | PRUCALOPRIDE (PRUCALOPRIDE SUCCINATE) 2 MG | Marketed |
| 02559013 | PRUCALOPRIDE | SANIS HEALTH INC | Tablet | PRUCALOPRIDE (PRUCALOPRIDE SUCCINATE) 2 MG | Marketed |
| 02559005 | PRUCALOPRIDE | SANIS HEALTH INC | Tablet | PRUCALOPRIDE (PRUCALOPRIDE SUCCINATE) 1 MG | Marketed |
| 02377020 | RESOTRAN | AMDIPHARM LIMITED | Tablet | PRUCALOPRIDE (PRUCALOPRIDE SUCCINATE) 2 MG | Marketed |
| 02377012 | RESOTRAN | AMDIPHARM LIMITED | Tablet | PRUCALOPRIDE (PRUCALOPRIDE SUCCINATE) 1 MG | Marketed |
| 02499959 | PMS-PRUCALOPRIDE | PHARMASCIENCE INC | Tablet | PRUCALOPRIDE (PRUCALOPRIDE SUCCINATE) 2 MG | Cancelled Pre Market |
Notices of Compliance
| NOC | Date | Submission | Reason |
|---|---|---|---|
| 23739 | 2020-06-05 | Abbreviated New Drug Submission (ANDS) |